KEMRI

KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya

Retrieved on: 
Tuesday, February 7, 2023
Data Management, Technology, University, Education, Biometrics, Hospitals, Children, Baby, Maternity, Clinical Trials, Science, Software, Networks, Consumer, Health, Research, Caregiver, Voice recognition, Human voice, NEC, Life, Hand, Hospital, Kinango, Vaccination, Electricity, Digital technology, Clinical trial, Kenya Medical Research Institute, Telecommunications, Nagasaki University, KEMRI, Death, Pharmaceutical industry, Vaccine

The Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC; TOKYO: 6701) and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.

Key Points: 
  • The Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC; TOKYO: 6701) and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.
  • Validation of this system is taking place through KEMRI with a clinical trial that began in September 2022 at the Kinango Sub-County Hospital in Kwale.
  • The digital system being provided by NEC, a leader in the integration of IT and network technologies, and KEMRI, one of Africa’s leading research Institutions, will effectively and seamlessly manage vaccination history and scheduling using fingerprint identification for newborn children and voice recognition for caregivers.
  • This technology marks the first time that biometric identification is being used at a hospital to identify newborn children at the time of vaccination, including those immediately after delivery (*1).

KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya

Retrieved on: 
Tuesday, February 7, 2023
Universal health care, Caregiver, Kinango, Nagasaki University, Hand, NEC, Death, SDG, Human, Child, Telecommunication, Life, Guideline, Hospital, Partnership, Finger, Medicine, Biometrics, KEMRI, COVID-19, Policy, Vaccine, Kenya Medical Research Institute, Mother, Digital technology, Name, Report, Hospital Records, Clinical trial, Mortality, Voice recognition, Electricity, Classification, Vaccination, Sustainable Development Goals, Research, Pharmaceutical industry, Security printing, Residential care

TOKYO, Feb 7, 2023 - (JCN Newswire) - Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC) and Nagasaki University, Japan, have developed a digital biometric-based vaccination management system for newborn children in Kenya.

Key Points: 
  • TOKYO, Feb 7, 2023 - (JCN Newswire) - Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC) and Nagasaki University, Japan, have developed a digital biometric-based vaccination management system for newborn children in Kenya.
  • This technology marks the first time that biometric identification is being used at a hospital to identify newborn children at the time of vaccination, including those immediately after delivery(1).
  • As of November 2022, data from more than 300 caregivers and newborns had been registered, including the vaccination histories of more than 150 newborns.
  • (1) NEC research as of February 7, 2023
    (2) Source: Levels and trends in child mortality, Report 2021, UN-IGME

CFK Africa Hosts One of CDC’s Largest Overseas Population-Based Disease Surveillance Platforms

Retrieved on: 
Wednesday, June 1, 2022
Philanthropy, Health, Infectious Diseases, Foundation, General Health, Research, Science, Global health, Coronavirus, Pneumonia, Typhoid fever, Research, COVID-19, Rotavirus, Organic, Partnership, Policy, Kenya Medical Research Institute, Disease, CDC, CFK, Infection, Prevalence, Public health, KEMRI, Diarrhea, Vaccine

Since 2007, CFK Africa has partnered with the CDC in Kenya to conduct the surveillance activity among approximately 30,000 residents of Kibera, which is one of the largest informal settlements in Africa and located just outside of Nairobi's central business district.

Key Points: 
  • Since 2007, CFK Africa has partnered with the CDC in Kenya to conduct the surveillance activity among approximately 30,000 residents of Kibera, which is one of the largest informal settlements in Africa and located just outside of Nairobi's central business district.
  • The surveillance program focuses on monitoring infectious diseases such as pneumonia, diarrheal and febrile illnesses, as well as Covid-19, which was added during the pandemic.
  • We are also drawing on the data at CFK Africa to inform new interventions and strengthen our existing programming to meet emerging and increasing needs.
  • Over the years, the CDC's PBIDS initiatives have been established around the world and supported new interventions for rotavirus and a pneumococcal conjugate vaccine (PCV10).